AMAG Pharmaceuticals to Participate in the Jefferies Autumn 2015 Global Healthcare Conference in London
November 11 2015 - 8:16AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that
William Heiden, AMAG's chief executive officer, will present at the
Jefferies Autumn 2015 Global Healthcare Conference in London on
Wednesday, November 18, 2015 at 3:20 p.m. GMT. The session will
include a company presentation followed by a question and answer
period.
A live audio webcast of the presentation will be accessible
through the Investors section of the company's website at
www.amagpharma.com. Following the conference, the webcast will be
archived on the AMAG Pharmaceuticals website for 30 days.
About AMAG
As a specialty pharmaceutical company, AMAG Pharmaceuticals,
Inc. uses its business and clinical expertise to bring medical
therapies and other innovations to market that provide clear
benefits and improve people's lives. Based in Waltham,
Massachusetts, AMAG has a diverse portfolio of products in the
areas of maternal health, anemia management and cancer supportive
care. In addition to continuing to pursue opportunities to make new
advancements in patients' health and to enhance treatment
accessibility, AMAG intends to continue to expand and diversify its
portfolio through the in-license or purchase of additional
pharmaceutical products or companies. For additional company
information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc.
CONTACT: AMAG Pharmaceuticals Contact:
Maryann Cimino
Manager, Corporate Communications & External Affairs
617-498-3375
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2023 to Apr 2024